← Back to Discover
Bellevue Asset Management AG
Period ended Dec 31, 2015 · Latest filing Feb 12, 2016
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Dec 31, 2015: $656,311,000
More quarters will appear as history becomes available.
Top holdings
Top 10 at Dec 31, 2015. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Celgene Corporation · COM · 151020104 · shares: $26,037,000
- Biogen Inc. · COM · 09062X103 · shares: $25,743,000
- Gilead Sciences, Inc. · COM · 375558103 · shares: $24,298,000
- Amgen Inc. · COM · 031162100 · shares: $19,967,000
- Regeneron Pharmaceuticals, Inc. · COM · 75886F107 · shares: $19,760,000
- Medtronic, Inc. · COM · 585055106 · shares: $19,730,000
- Illumina, Inc. · COM · 452327109 · shares: $17,549,000
- Abbott Laboratories · COM · 002824100 · shares: $17,133,000
- Mylan Inc. · COM · 628530107 · shares: $17,048,000
- Becton, Dickinson and Company · COM · 075887109 · shares: $16,191,000
Filing totals differ
The filing summary reports $656,311,000, while the holdings entries total $656,313,000.
Reported holdings
127 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Celgene Corporation | COM | 151020104 | — | 217,410 shares | $26,037,000 |
| Biogen Inc. | COM | 09062X103 | — | 84,030 shares | $25,743,000 |
| Gilead Sciences, Inc. | COM | 375558103 | — | 240,120 shares | $24,298,000 |
| Amgen Inc. | COM | 031162100 | — | 123,000 shares | $19,967,000 |
| Regeneron Pharmaceuticals, Inc. | COM | 75886F107 | — | 36,400 shares | $19,760,000 |
| Medtronic, Inc. | COM | 585055106 | — | 256,500 shares | $19,730,000 |
| Illumina, Inc. | COM | 452327109 | — | 91,425 shares | $17,549,000 |
| Abbott Laboratories | COM | 002824100 | — | 381,500 shares | $17,133,000 |
| Mylan Inc. | COM | 628530107 | — | 315,300 shares | $17,048,000 |
| Becton, Dickinson and Company | COM | 075887109 | — | 105,075 shares | $16,191,000 |
| Cardinal Health, Inc. | COM | 14149Y108 | — | 171,480 shares | $15,308,000 |
| UnitedHealth Group Incorporated | COM | 91324P102 | — | 120,000 shares | $14,117,000 |
| Stryker Corporation | COM | 863667101 | — | 140,700 shares | $13,077,000 |
| Teva Pharmaceuticals, Inc. | ADR | 881624209 | — | 176,720 shares | $11,600,000 |
| Express Scripts Holding Company | COM | 30219G108 | — | 124,000 shares | $10,839,000 |
| Endo International PLC | SHS | G30401106 | — | 171,000 shares | $10,469,000 |
| Auris Medical Holding AG | COM | H03579101 | — | 2,169,625 shares | $10,414,000 |
| Zimmer Holdings, Inc. | COM | 98956P102 | — | 95,500 shares | $9,797,000 |
| Alexion Pharmaceuticals, Inc. | COM | 015351109 | — | 49,400 shares | $9,423,000 |
| CVS Health Corporation | COM | 126650100 | — | 96,200 shares | $9,405,000 |
| Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | — | 81,640 shares | $8,851,000 |
| Incyte Corporation | COM | 45337C102 | — | 79,000 shares | $8,568,000 |
| Ionis Pharmaceuticals Inc. | COM | 462222100 | — | 138,000 shares | $8,546,000 |
| Boston Scientific Corporation | COM | 101137107 | — | 460,000 shares | $8,482,000 |
| McKesson Corporation | COM | 58155Q103 | — | 43,000 shares | $8,481,000 |
| Jazz Pharmaceuticals Public Limited Company | SHS USD | G50871105 | — | 60,000 shares | $8,434,000 |
| Vertex Pharmaceuticals Incorporated | COM | 92532F100 | — | 67,000 shares | $8,431,000 |
| St. Jude Medical, Inc. | COM | 790849103 | — | 122,000 shares | $7,536,000 |
| Cigna Corporation | COM | 125509109 | — | 48,000 shares | $7,024,000 |
| Centene Corporation | COM | 15135B101 | — | 105,630 shares | $6,952,000 |
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | — | 65,000 shares | $6,809,000 |
| Insys Therapeutics, Inc. | COM NEW | 45824V209 | — | 232,000 shares | $6,642,000 |
| AmerisourceBergen Corporation | COM | 03073E105 | — | 64,000 shares | $6,637,000 |
| Perrigo Company plc | SHS | G97822103 | — | 44,000 shares | $6,367,000 |
| Shire PLC | SPONSORED ADR | 82481R106 | — | 30,820 shares | $6,318,000 |
| Intuitive Surgical, Inc. | COM NEW | 46120E602 | — | 11,550 shares | $6,308,000 |
| Coherus BioSciences, Inc | COM | 19249H103 | — | 257,000 shares | $5,901,000 |
| Aetna Inc. | COM | 00817Y108 | — | 53,000 shares | $5,730,000 |
| Halozyme Therapeutics, Inc. | COM | 40637H109 | — | 318,000 shares | $5,511,000 |
| Edwards Lifesciences Corporation | COM | 28176E108 | — | 69,000 shares | $5,450,000 |
| Humana, Inc. | COM | 444859102 | — | 30,000 shares | $5,355,000 |
| Horizon Pharma plc | SHS | G4617B105 | — | 245,000 shares | $5,309,000 |
| Alkermes Public Limited Company | SHS | G01767105 | — | 65,500 shares | $5,199,000 |
| Johnson & Johnson | COM | 478160104 | — | 50,000 shares | $5,136,000 |
| C.R. Bard, Inc. | COM | 067383109 | — | 27,000 shares | $5,115,000 |
| Mallinckrodt public limited company | SHS | G5785G107 | — | 68,000 shares | $5,075,000 |
| Intersect Ent, Inc. | COM | 46071F103 | — | 225,000 shares | $5,063,000 |
| EAGLE PHARMACEUTICALS INC | COM | 268948106 | — | 55,000 shares | $4,877,000 |
| Supernus Pharmaceuticals, Inc. | COM | 868459108 | — | 355,000 shares | $4,771,000 |
| Community Health Systems, Inc. | COM | 203668108 | — | 174,440 shares | $4,628,000 |
| Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | — | 420,000 shares | $4,532,000 |
| Lannett Inc. | COM | 516012101 | — | 107,480 shares | $4,312,000 |
| Baxter International Inc. | COM | 071813109 | — | 110,000 shares | $4,197,000 |
| Anthem, Inc. | COM | 036752103 | — | 30,000 shares | $4,183,000 |
| Bristol-Myers Squibb Company | COM | 110122108 | — | 60,000 shares | $4,127,000 |
| HCA Holdings, Inc. | COM | 40412C101 | — | 60,000 shares | $4,058,000 |
| Neurocrine Biosciences, Inc. | COM | 64125C109 | — | 65,000 shares | $3,677,000 |
| Nektar Therapeutics | COM | 640268108 | — | 216,000 shares | $3,640,000 |
| Cerner Corporation | COM | 156782104 | — | 60,000 shares | $3,610,000 |
| Pfizer Inc. | COM | 717081103 | — | 110,000 shares | $3,551,000 |
| Agios Pharmaceuticals, Inc. | COM | 00847X104 | — | 54,000 shares | $3,506,000 |
| Novadaq Technologies Inc. | COM | 66987G102 | — | 250,000 shares | $3,185,000 |
| Merck & Co., Inc. | COM | 58933Y105 | — | 60,000 shares | $3,169,000 |
| Hologic, Inc. | COM | 436440101 | — | 81,000 shares | $3,134,000 |
| Masimo Corporation | COM | 574795100 | — | 75,000 shares | $3,113,000 |
| ARIAD Pharmaceuticals, Inc. | COM | 04033A100 | — | 495,000 shares | $3,094,000 |
| Seattle Genetics, Inc. | COM | 812578102 | — | 68,000 shares | $3,052,000 |
| Medivation, Inc. | COM | 58501N101 | — | 63,000 shares | $3,045,000 |
| Varian Medical Systems, Inc. | COM | 92220P105 | — | 37,000 shares | $2,990,000 |
| Lilly Eli & Co. | COM | 532457108 | — | 35,000 shares | $2,949,000 |
| Thermo Fisher Scientific Inc. | COM | 883556102 | — | 20,000 shares | $2,837,000 |
| Novavax, Inc. | COM | 670002104 | — | 325,000 shares | $2,727,000 |
| Macrogenics, Inc. | COM | 556099109 | — | 83,000 shares | $2,571,000 |
| Qiagen NV | REG SHS | N72482107 | — | 91,500 shares | $2,530,000 |
| Celldex Therapeutics, Inc. | COM | 15117B103 | — | 160,000 shares | $2,509,000 |
| Cooper Companies Inc. | COM NEW | 216648402 | — | 18,500 shares | $2,483,000 |
| Radius Health Inc. | COM NEW | 750469207 | — | 40,000 shares | $2,462,000 |
| Globus Medical, Inc. | CL A | 379577208 | — | 87,700 shares | $2,440,000 |
| Teleflex Incorporated | COM | 879369106 | — | 18,557 shares | $2,439,000 |
| Nuvasive, Inc. | COM | 670704105 | — | 45,000 shares | $2,435,000 |
| Healthcare Services Group Inc. | COM | 421906108 | — | 65,000 shares | $2,267,000 |
| Alnylam Pharmaceuticals Inc. | COM | 02043Q107 | — | 24,000 shares | $2,259,000 |
| Zeltiq Aesthetics Inc. | COM | 98933Q108 | — | 75,000 shares | $2,140,000 |
| Prothena Corporation plc | SHS | G72800108 | — | 31,000 shares | $2,111,000 |
| Intercept Pharmaceuticals, Inc. | COM | 45845P108 | — | 13,500 shares | $2,016,000 |
| Bluebird Bio, Inc. | COM | 09609G100 | — | 29,000 shares | $1,862,000 |
| Clovis Oncology, Inc. | COM | 189464100 | — | 52,500 shares | $1,838,000 |
| Stericycle, Inc. | COM | 858912108 | — | 15,000 shares | $1,809,000 |
| PTC Therapeutics Inc. | COM | 69366J200 | — | 55,000 shares | $1,782,000 |
| Inovio Pharmaceuticals, Inc. | COM NEW | 45773H201 | — | 265,000 shares | $1,781,000 |
| Wright Medical Group Inc. | ORD SHS 0.03 PAR | N96617118 | — | 70,309 shares | $1,700,000 |
| Juno Therapeutics, Inc. | COM | 48205A109 | — | 37,000 shares | $1,627,000 |
| Acadia Pharmaceuticals, Inc. | COM | 004225108 | — | 45,000 shares | $1,604,000 |
| WellCare Health Plans, Inc. | COM | 94946T106 | — | 20,000 shares | $1,564,000 |
| United Therapeutics Corporation | COM | 91307C102 | — | 9,300 shares | $1,456,000 |
| Davita Healthcare Partners, Inc. | COM | 23918K108 | — | 20,000 shares | $1,394,000 |
| Infinity Pharmaceuticals, Inc. | COM | 45665G303 | — | 160,000 shares | $1,256,000 |
| Laboratory Corporation of America Holdings | COM NEW | 50540R409 | — | 10,000 shares | $1,236,000 |
| AngioDynamics, Inc. | COM | 03475V101 | — | 100,000 shares | $1,214,000 |
| Ultragenyx Pharmaceuticals Inc. | COM | 90400D108 | — | 10,000 shares | $1,122,000 |